Navigation Links
Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Date:4/30/2008

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced it has re-scheduled its presentation time at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, FL to Thursday, May 1, 2008 at 3:00 p.m. ET / 12:00 p.m. PT. Previously, the presentation had been scheduled for 9:20 a.m. ET / 6:20 a.m. PT. Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. Amylin Pharmaceuticals to Webcast First Quarter Results
3. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
5. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
6. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
7. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
8. Amylin Pharmaceuticals Reports Third Quarter Financial Results
9. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
10. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
11. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...   Mapi expands Pharmacovigilance and Risk ... global Risk Management strength with the expanded breadth ... . Pharmacovigilance and Risk ... team that includes physicians, pharmacists, and numerous other ... navigating complex safety requirements throughout the product lifecycle. ...
(Date:3/31/2015)...  University of Illinois, Swanlund ... plenary session address on Monday, May 18 at the ... kicking off a week of more than 160 technical ... RF and microwave technologies with health. Dr. ... Circuits for the Skin," will focus on the experimental ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Diasome Pharmaceuticals, ... licensor, SDG, Inc., that a United States patent has ... insulin therapy. , Entitled “Lipid Construct for ... composition of matter claims related to the use of ... for enabling injected insulin to more effectively reach the ...
(Date:3/30/2015)... Winston-Salem, NC (PRWEB) March 30, 2015 ... Associates are pleased to announce the formation of ... clinical research centers specializing in the conduct of ... populations. VaxCorps clinical sites have successfully conducted ... extensive experience in seasonal and pandemic influenza as ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2
... Savvier consumers and competition from generic drugs have made ... maturity, more elusive.  At the same time, new technologies ... to support pharmaceutical brand growth. While biopharma ... brands, recent field research from Best Practices, LLC suggests ...
... 30, 2011 Amnis Corporation, a manufacturer of advanced cell ... by EMD Millipore, the Life Science division of Merck KGaA ... closing is expected to take place in the fourth quarter ... Amnis generated sales of USD 14 million ...
... crucial to preventing countless human diseases. In a recent ... a new approach for studying molecules within their natural ... how bacteria infect people. The research, led by ... in the Proceedings of the National Academy of ...
Cached Biology Technology:Using Public Relations to Launch, Grow, and Extend Pharmaceutical and Biotech Brands 2Amnis Acquired by EMD Millipore - Expands Growth Potential 2Amnis Acquired by EMD Millipore - Expands Growth Potential 3Scientists develop new technologies for understanding bacterial infections 2Scientists develop new technologies for understanding bacterial infections 3
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... -- Continuing its 167-year history of offering the Best, the ... Eye Scanning Password Authenticator , a device that confirms ... or sensitive data. Employing the same biometric ... device has a small camera that scans and saves ... them into an encrypted ID that cannot be forged ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... Tenn., April 21, 2008 Improved management of crops ... the problem of hypoxia, which claims thousands of fish, ... spring. An assessment by a team led by ... Division concludes that low oxygen levels in water, or ...
... Virginia Bioinformatics Institute (VBI) at Virginia Tech and their ... family of virulence proteins that play an important role ... pathogen Phytophthora sojae. VBI Professor Brett Tyler ... from Virginia Techs Department of Plant Pathology, Physiology and ...
... results of a University of Illinois study have demonstrated an ... bars. Eating two CocoaVia dark chocolate bars a day ... also lowering systolic blood pressure, said John Erdman, a U. ... The study, funded in part by Mars Inc., the company ...
Cached Biology News:Crop management strategies key to a healthy Gulf, planet 2Crop management strategies key to a healthy Gulf, planet 3Chocolate bar shown to lower cholesterol 2
... The Ph.D. Peptide Display Cloning System ... on the surface of bacteriophage M13 as ... between each displayed peptide and its encoding ... of targets can then be selected by ...
... Detection of the yolk protein Vtg in ... simple and sensitive biomarker for endocrine disrupting chemicals ... Vtg has become an accepted screening test for ... Vtg (rainbow trout) EIA kit is a double-antibody ...
... synthetic peptide whose sequence corresponds to residues 115-133 of rat SAP97. ... V115 - L - P - S - E - ... - P - N - E - V - L - ... added to facilitate conjugation and is not a part of the ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
Biology Products: